NEW YORK, April 4 (GenomeWeb News) - The Chang-Gung Memorial Hospital has expanded its use of Bruker Daltonics mass-spectrometry instrumentation to include one of its operating clinics in Kaohsiung, the hospital said today.
CGMH, based in Taipei, implemented a Bruker ClinProt system for MALDI-TOF mass spectrometry-based clinical proteomics and biomarker analysis at its facility in Linkou last year. Now, it will establish a similar ClinProt set up in
Additionally, the existing ClinProt platform in Linkou will be expanded by additional sample preparation and mass spectrometry technologies to analyze and identify potential protein biomarkers, CGMH said.
Specific terms of CGMH's arrangement with Bruker were not disclosed.